Page 22 - ARNM-3-1

Advances in Radiotherapy
& Nuclear Medicine Diagnostics gude of biliary tract cancer

57. Wakiya T, Ishido K, Kimura N, et al. CT-based deep learning doi: 10.1007/s00330-020-07524-y
enables early postoperative recurrence prediction for 69. Sheng R, Huang X, Jin K, et al. Contrast-enhanced
intrahepatic cholangiocarcinoma. Sci Rep. 2022;12(1):8428. MRI could predict response of systemic therapy in
doi: 10.1038/s41598-022-12604-8 advanced intrahepatic cholangiocarcinoma. Eur Radiol.
2022;32(8):5156-5165.
58. Bliznakova K, Kolev N, Buliev I, et al. Computer aided
preoperative evaluation of the residual liver volume doi: 10.1007/s00330-022-08679-6
using computed tomography images. J Digit Imaging. 70. Koh J, Chung YE, Nahm JH, et al. Intrahepatic mass-forming
2015;28(2):231-239. cholangiocarcinoma: Prognostic value of preoperative
doi: 10.1007/s10278-014-9737-5 gadoxetic acid-enhanced MRI. Eur Radiol. 2016;26(2):407-416.
59. Sainani NI, Catalano OA, Holalkere NS, Zhu AX, Hahn PF, doi: 10.1007/s00330-015-3846-5
Sahani DV. Cholangiocarcinoma: Current and novel imaging 71. Wang L, Liu J, Zeng Y, Shu J. The value of an MRI-based
techniques. Radiographics. 2008;28(5):1263-1287. radiomics model in predicting the survival and prognosis
doi: 10.1148/rg.285075183 of patients with extrahepatic cholangiocarcinoma. Cancer
Med. 2024;13(1):e6832.
60. Fred HL. Drawbacks and limitations of computed
tomography: Views from a medical educator. Tex Heart Inst doi: 10.1002/cam4.6832
J. 2004;31(4):345-348. 72. Xin Y, Liu Q, Zhang J, et al. Hilar cholangiocarcinoma:
61. Vilgrain V, Van Beers BE, Flejou JF, et al. Intrahepatic Value of high-resolution enhanced magnetic resonance
cholangiocarcinoma: MRI and pathologic correlation in imaging for preoperative evaluation. J Cancer Res Ther.
14 patients. J Comput Assist Tomogr. 1997;21(1):59-65. 2020;16(7):1634-1640.
doi: 10.4103/jcrt.JCRT_140_20
doi: 10.1097/00004728-199701000-00012
73. Min JH, Kim YK, Choi SY, et al. Intrahepatic mass-forming
62. Jhaveri KS, Hosseini-Nik H. MRI of cholangiocarcinoma.
J Magn Reson Imaging. 2015;42(5):1165-1179. cholangiocarcinoma: Arterial enhancement patterns at MRI
and prognosis. Radiology. 2019;290(3):691-699.
doi: 10.1002/jmri.24810
doi: 10.1148/radiol.2018181485
63. Zhimin G, Noor H, Jian-Bo Z, Lin W, Jha RK. Advances
in diagnosis and treatment of hilar cholangiocarcinoma--a 74. Vanderveen KA, Hussain HK. Magnetic resonance imaging
of cholangiocarcinoma. Cancer Imaging. 2004;4(2):104-115.
review. Med Sci Monit. 2013;19:648-656.
doi: 10.1102/1470-7330.2004.0018
doi: 10.12659/MSM.889379
75. Kovač JD, Janković A, Đikić-Rom A, Grubor N, Antić A,
64. Manfredi R, Barbaro B, Masselli G, Vecchioli A, Marano P. Dugalić V. Imaging spectrum of intrahepatic mass-forming
Magnetic resonance imaging of cholangiocarcinoma. Semin cholangiocarcinoma and its mimickers: How to differentiate
Liver Dis. 2004;24(2):155-164.
them using MRI. Curr Oncol. 2022;29(2):698-723.
doi: 10.1055/s-2004-828892 doi: 10.3390/curroncol29020061
65. Masselli G, Gualdi G. Hilar cholangiocarcinoma: MRI/ 76. Singh A, Siddiqui UD. The role of endoscopy in the
MRCP in staging and treatment planning. Abdom Imaging. diagnosis and management of cholangiocarcinoma. J Clin
2008;33(4):444-451. Gastroenterol. 2015;49(9):725-737.
doi: 10.1007/s00261-007-9281-6 doi: 10.1097/MCG.0000000000000390
66. Kim DW, Kim SY, Yoo C, Hwang DW. Update on biliary 77. Voigtländer T, Lankisch TO. Endoscopic diagnosis
cancer imaging. Radiol Clin North Am. 2022;60(5):825-842. of cholangiocarcinoma: From endoscopic retrograde
doi: 10.1016/j.rcl.2022.05.001 cholangiography to bile proteomics. Best Pract Res Clin
Gastroenterol. 2015;29(2):267-275.
67. Xu Y, Ye F, Li L, et al. MRI-based radiomics nomogram for
preoperatively differentiating intrahepatic mass-forming doi: 10.1016/j.bpg.2015.02.005
cholangiocarcinoma from resectable colorectal liver 78. Vogel A, Wege H, Caca K, Nashan B, Neumann U. The
metastases. Acad Radiol. 2023;30(9):2010-2020. diagnosis and treatment of cholangiocarcinoma. Dtsch
doi: 10.1016/j.acra.2023.04.030 Arztebl Int. 2014;111(44):748-754.
68. Zhang J, Wu Z, Zhao J, et al. Intrahepatic doi: 10.3238/arztebl.2014.0748
cholangiocarcinoma: MRI texture signature as predictive 79. Rizvi S, Gores GJ. Current diagnostic and management
biomarkers of immunophenotyping and survival. Eur options in perihilar cholangiocarcinoma. Digestion.
Radiol. 2021;31(6):3661-3672. 2014;89(3):216-224.

Volume 3 Issue 1 (2025) 14 doi: 10.36922/arnm.4557